Grand Central Investment Group’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.17M Buy
1,813
+142
+8% +$145K 1.82% 21
2026
Q1
$1.54M Buy
1,671
+132
+9% +$134K 1.14% 24
2025
Q4
$1.65M Buy
+1,539
New +$1.47M 1.2% 25

Other funds holding LLY

Grand Central Investment Group's LLY Position: Q2 2026 in Review

Grand Central Investment Group increased its Eli Lilly (LLY) stake by 8.5% in Q2 2026, buying an estimated $145K and bringing the position to 1,813 shares worth $2.17M. The position accounts for 1.82% of the portfolio, ranked #21.

Grand Central Investment Group first reported a position in LLY in Q4 2025 and has held it in 3 quarters since. 4,630 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Grand Central Investment Group held 1,813 shares of Eli Lilly worth $2.17M as of Q2 2026.
  • Grand Central Investment Group bought 142 Eli Lilly shares in Q2 2026, an estimated $145K.
  • Eli Lilly made up 1.82% of Grand Central Investment Group's portfolio in Q2 2026, its #21 holding.
  • Grand Central Investment Group first reported a position in Eli Lilly in Q4 2025 and has held it in 3 quarters since.
  • 4,630 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Grand Central Investment Group's 13F filing for Q2 2026, filed 4 Aug 2026.